2,3-diaminopropionic acid has been researched along with gastrin-releasing peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Figureoa, SD; Heinzke, L; Hoffman, TJ; Ma, L; Retzloff, LB; Rold, TL; Santos, I; Sieckman, GL; Smith, CJ; Sublett, SV | 1 |
1 other study(ies) available for 2,3-diaminopropionic acid and gastrin-releasing peptide
Article | Year |
---|---|
Evaluation of [99mTc-(CO)3-X-Y-Bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma.
Topics: Animals; beta-Alanine; Bombesin; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Gastrin-Releasing Peptide; Humans; Mice; Mice, Inbred ICR; Mice, SCID; Organotechnetium Compounds; Pyrazoles; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2010 |